Specify Company / Ticker to Get the Summary
Dividend History ADIL
Dividend Analytics ADIL
Max Ratio
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Adial Pharmaceuticals Inc
ADILAdial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Glen Allen, Virginia. Address: 4870 Sadler Road, Glen Allen, VA, United States, 23060
Analytics
WallStreet Target Price
4.00 USDP/E Ratio
–Dividend Yield
–Financials ADIL
Results | 2019 | Dynamics |